LEMAITRE VASCULAR, INC. Contract Liability (Deferred Revenue)
LEMAITRE VASCULAR, INC. (LMAT) had Contract Liability (Deferred Revenue) of $188.00 thousand as of 2019-06-30, per its 10-Q filed 2019-08-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2020-03-12
- 2019-06-30: Contract with Customer, Liability, Current $188.00K.
- 2019-03-31: Contract with Customer, Liability, Current $368.00K.
- 2018-12-31: Contract with Customer, Liability, Current $552.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2019-06-30 | $188.00K 10-Q · filed 2019-08-06 |
| 2019-03-31 | $368.00K 10-Q · filed 2019-05-06 |
| 2018-12-31 | $552.00K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |